deltatrials
Recruiting PHASE2 INTERVENTIONAL 2-arm NCT04844528

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

Randomized Phase 2 Studying the Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia (CLL) With History of Non-melanoma Skin Cancers (NMSC)

Sponsor: Huntsman Cancer Institute

Conditions Chronic Lymphocytic Leukemia Non-melanoma Skin Cancer (NMSC)
Interventions Nicotinamide Placebo
Updated 11 times since 2021 Last updated: Nov 25, 2025 Started: Feb 25, 2022 Primary completion: Aug 31, 2026 Completion: Aug 31, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04844528, this PHASE2 trial focuses on Chronic Lymphocytic Leukemia and Non-melanoma Skin Cancer (NMSC) and remains actively recruiting participants. Sponsored by Huntsman Cancer Institute, it has been updated 11 times since 2022, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~May 2021 – ~Sep 2021 · 4 months · monthly snapshotNot Yet Recruiting~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshotRecruiting~Oct 2021 – ~Feb 2022 · 4 months · monthly snapshotSuspended~Feb 2022 – ~Feb 2023 · 12 months · monthly snapshotRecruiting~Feb 2023 – ~Apr 2023 · 59 days · monthly snapshotRecruiting~Apr 2023 – ~Mar 2024 · 11 months · monthly snapshotRecruiting~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Oct 2025 · 13 months · monthly snapshotRecruiting~Oct 2025 – ~Jan 2026 · 3 months · monthly snapshotRecruiting~Jan 2026 – present · 5 months · monthly snapshotRecruiting

Change History

11 versions recorded

  1. Jan 2026 — Present [monthly]

    Recruiting PHASE2

  2. Oct 2025 — Jan 2026 [monthly]

    Recruiting PHASE2

  3. Sep 2024 — Oct 2025 [monthly]

    Recruiting PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  5. Mar 2024 — Jul 2024 [monthly]

    Recruiting PHASE2

▶ Show 6 earlier versions

  1. Apr 2023 — Mar 2024 [monthly]

    Recruiting PHASE2

  2. Feb 2023 — Apr 2023 [monthly]

    Recruiting PHASE2

  3. Feb 2022 — Feb 2023 [monthly]

    Recruiting PHASE2

    Status: Suspended → Recruiting

  4. Oct 2021 — Feb 2022 [monthly]

    Suspended PHASE2

    Status: Recruiting → Suspended

  5. Sep 2021 — Oct 2021 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  6. May 2021 — Sep 2021 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Huntsman Cancer Institute
  • University of Utah
Data source: University of Utah

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations